drug
emrusolmin
Phase 2updated 6mo agoby $TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
News(2)
- UniQure gets an FDA decision date; Teva scraps brain drug studyThe FDA appears likely to hold an advisory committee for UniQure’s closely watched Huntington’s disease gene therapy. Elsewhere, a biotech’s share price was cut in half following a regulatory setback.biopharma_dive · 13d ago
- Teva ends trial of one of its original line-up of innovative meds over futilityTeva has given up on a key trial of one of its original line-up of innovative medicines.fiercebiotech · 15d ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that